Scientific Session
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Michael Brenner, MD
Brigham and Women's Hospital, Harvard Medical School
Newton, MA, United States
Disclosure(s): 4FO Ventures: Consultant (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Mestag Therapeutics: Consultant (Ongoing), Stock options or bond holdings in a for-profit corporation or self-directed pension plan (Ongoing); Third Rock Ventures: Consultant (Ongoing)